The NNSA intends to grant SHINE Technologies cost-share funding to build and operate a new facility for producing the medical isotope molybdenum-99 (Mo-99) without the use of highly-enriched uranium, according to a March 4 filing in the Federal Register.
The agency…
SUBSCRIBER ACCESS
Thank you for visiting
Weapons Complex Morning Briefing!
You must be logged in as a subscriber to view this page.



